Search

The article offers information on illnesses following presumed cosmetic Botulinum Neurotoxin (BoNT) injections in nonmedical settings in Tennessee and New York City in March 2024. Topics include the clinical manifestations observed among patients, such as ptosis, dysphagia, and weakness; the multistate investigation involving health departments, FDA, and CDC to identify the source of counterfeit BoNT products; and the management of affected patients.

The article reports that New York City (NYC) has become foci of monkeypox (Mpox) outbreak in May 2022. It mentions that investigation data from mpox cases reported to the NYC Department of Health and Mental Hygiene (DOHMH) surveillance system have a high degree of completeness for gender, race or ethnicity, sexual orientation, and clinical signs and symptoms.

The article presents a report on severe Bartonella (B.) quintana infections among persons experiencing unsheltered homelessness in New York City (NYC) from January 2020 to December 2022. Topics include cases of B. quintana infection that occurred among persons experiencing unsheltered homelessness in NYC, possible outcomes of B. quintana infection, and demographic information, clinical features, risk factors, and outcomes of persons experiencing homelessness with B. quintana infection.

After being notified that 2 high school football teammates from New York City were hospitalized with confirmed or suspected invasive group A streptococcal infections, we conducted an investigation of possible spread among other team members. This investigation highlights a need for guidelines on management of streptococcal and other infectious disease outbreaks in team sport settings. [ABSTRACT FROM AUTHOR]

An outbreak of respiratory illness occurred in a long-term care facility in New York City. Investigation of the outbreak identified confirmed or suspected adenoviral infection in 84% of the residents from October 19 to December 18, 1999. Further identification by type-specific neutralization and restriction analysis identified a new genomic variant of adenovirus type 7. [ABSTRACT FROM AUTHOR]

Presents a study that determined the sources of exposure and identified persons at risk from inhalational anthrax in New York City in November 2001. Culture of all specimens for Bacillus anthracis; Absence of additional cases of cutaneous or inhalational anthrax; Route of exposure.

In late October 2014, Ebola virus disease (Ebola) was diagnosed in a humanitarian aid worker who recently returned from West Africa to New York City (NYC). The NYC Department of Health and Mental Hygiene (DOHMH) actively monitored three close contacts of the patient and 114 health care personnel. No secondary cases of Ebola were detected. In collaboration with local and state partners, DOHMH had developed protocols to respond to such an event beginning in July 2014. These protocols included safely transporting a person at the first report of symptoms to a local hospital prepared to treat a patient with Ebola, laboratory testing for Ebola, and monitoring of contacts. In response to this single case of Ebola, initial health care worker active monitoring protocols needed modification to improve clarity about what types of exposure should be monitored. The response costs were high in both human resources and money: DOHMH alone spent $4.3 million. However, preparedness activities that include planning and practice in effectively monitoring the health of workers involved in Ebola patient care can help prevent transmission of Ebola. [ABSTRACT FROM AUTHOR]

The article discusses the establishment of Ebola virus disease surveillance and management systems by the New York City Department of Health and Mental Hygiene (DOHHM). Topics explored include the collaboration between the DOHMH and local hospitals, the need to identify Ebola patients immediately to effectively implement Ebola virus infection control procedures, and the proper isolation of suspected Ebola virus disease patients that show symptoms like fever and unexplained hemorrhage.